Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 11.00
-0.40 (-3.51%)
Last updated: Mar 6, 2026, 9:00 AM CET
Vytrus Biotech Revenue
Vytrus Biotech had revenue of 3.06M EUR in the half year ending December 31, 2024, with 46.56% growth. This brings the company's revenue in the last twelve months to 8.09M, up 54.38% year-over-year. In the year 2024, Vytrus Biotech had annual revenue of 6.09M with 29.51% growth.
Revenue (ttm)
8.09M
Revenue Growth
+54.38%
P/S Ratio
10.24
Revenue / Employee
218.52K
Employees
37
Market Cap
82.77M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Almirall | 1.11B |
| Faes Farma | 571.12M |
| Prim, S.A. | 240.68M |
| Oryzon Genomics | 7.36M |
| Atrys Health | 226.24M |
| Laboratorio Reig Jofre | 336.68M |